Family Medicine · Kirkwood, MO
NPI
1174733620
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
816 S Kirkwood Rd Ste 210
Kirkwood, MO, 63122
Phone (314) 822-6830
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
1,707 services
Medicare patients, 2024
302
Average age 71
Drug cost, 2024
$1.6M
14,795 prescriptions
Company payments, 2025
$34.76
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin P King was code 99214 (office e&m - established), 403 times for 244 patients. In total Kevin P King billed 1,707 services in 50 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 403 | 244 | $80.49 | $32K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 180 | 180 | $124.48 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 91 | 70 | $12.32 | $1,121 |
| G0008 Administration of influenza virus vaccine | Office | 72 | 69 | $31.21 | $2,247 |
| 99213 Office E&M - Established | Office | 71 | 58 | $52.97 | $3,761 |
| 90662 Vaccine Product | Office | 59 | 57 | $81.48 | $4,808 |
| 83036 Blood Count | Office | 53 | 43 | $9.20 | $488 |
| 90677 Vaccine Product | Office | 13 | 13 | $289.96 | $3,769 |
| G0009 Administration of pneumococcal vaccine | Office | 13 | 13 | $31.21 | $406 |
| 81003 Clinical Chemistry | Office | 12 | 11 | $2.20 | $26.4 |
| 90656 Vaccine Product | Office | 11 | 11 | $21.90 | $241 |
By year: 2022 $100K for 2,493 services; 2023 $90K for 1,580 services; 2024 $78K for 1,707 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 53 | 43 | $9.20 | $488 |
| 81003 Clinical Chemistry | 12 | 11 | $2.20 | $26.4 |
Medicare prescription drug claims, 2024
In 2024, the drug Kevin P King prescribed most often to Medicare patients was Shingrix (Varicella-Zoster Ge/As01b/Pf), with 1,625 prescriptions and refills. In total Kevin P King wrote 14,795 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Shingrix Varicella-Zoster Ge/As01b/Pf | 1,625 | 1,628 | 1,202 | $344K |
| Atorvastatin Calcium Generic | 756 | 2,074 | 206 | $6,337 |
| Boostrix Tdap Diphth,pertuss(Acell),tet Vac | 687 | 687 | 686 | $45K |
| Amlodipine Besylate Generic | 430 | 1,094 | 107 | $2,017 |
| Losartan Potassium Generic | 421 | 1,114 | 109 | $2,894 |
| Levothyroxine Sodium Generic | 387 | 983 | 92 | $3,643 |
| Hydrochlorothiazide Generic | 385 | 959 | 94 | $1,510 |
| Lisinopril Generic | 336 | 899 | 91 | $2,103 |
| Sertraline Hcl Generic | 302 | 557 | 47 | $1,983 |
| Metformin Hcl Er Metformin Hcl | 299 | 790 | 79 | $3,936 |
| Omeprazole Generic | 269 | 680 | 69 | $3,936 |
| Duloxetine Hcl Generic | 212 | 454 | 47 | $3,925 |
| Alprazolam Generic | 211 | 228 | 47 | $1,429 |
| Gabapentin Generic | 200 | 451 | 54 | $3,961 |
| Trazodone Hcl Generic | 199 | 405 | 40 | $1,102 |
Brand drugs: 3,919 claims; generic drugs: 10,795 claims; opioid claims: 433.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin P King $34.76 ($34.76 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $34.76.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $34.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.